Oric Pharmaceuticals, Inc. (ORIC)
7.36
-0.34
(-4.42%)
USD |
NASDAQ |
Nov 20, 16:00
7.35
-0.01
(-0.14%)
After-Hours: 20:00
Oric Pharmaceuticals Shareholders Equity (Quarterly) : 339.50M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 339.50M |
| June 30, 2026 | 381.26M |
| March 31, 2026 | 415.56M |
| December 31, 2025 | 384.36M |
| September 30, 2025 | 406.92M |
| June 30, 2025 | 324.00M |
| March 31, 2025 | 219.74M |
| December 31, 2024 | 243.12M |
| September 30, 2024 | 273.99M |
| June 30, 2024 | 302.40M |
| March 31, 2024 | 328.64M |
| December 31, 2023 | 224.09M |
| September 30, 2023 | 247.41M |
| June 30, 2023 | 268.80M |
| Date | Value |
|---|---|
| March 31, 2023 | 202.81M |
| December 31, 2022 | 222.35M |
| September 30, 2022 | 214.82M |
| June 30, 2022 | 236.87M |
| March 31, 2022 | 253.08M |
| December 31, 2021 | 272.98M |
| September 30, 2021 | 291.54M |
| June 30, 2021 | 258.32M |
| March 31, 2021 | 276.08M |
| December 31, 2020 | 289.78M |
| September 30, 2020 | 184.38M |
| June 30, 2020 | 195.25M |
| March 31, 2020 | 79.64M |
| December 31, 2019 | 87.97M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 366.89M |
| Total Liabilities (Quarterly) | 27.38M |
| Debt to Equity Ratio | 0.0099 |
| Current Ratio | 11.09 |
| Net Debt Paydown Yield | 0.00% |